Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Donate to Science & Enterprise

Please share Science & Enterprise

Addiction Biotech Using Crowdfunding for Investments

Clock and coins graphic

A start-up enterprise developing treatments for drug and alcohol addiction is raising investment capital with a direct pitch to small investors through a crowdfunding platform. . . . → Read More: Addiction Biotech Using Crowdfunding for Investments

Eye Disease Gene-Therapy Biotech Adds Venture Funds

Monitor eyes

A biotechnology company designing treatments for inherited eye diseases with Crispr gene editing is raising €75 million in venture financing. . . . → Read More: Eye Disease Gene-Therapy Biotech Adds Venture Funds

Cell, mRNA Therapy Biotech Raises $165M in Early Funds

T-cells illustration

A new company, founded by university medical researchers, is developing cell therapies engineered with messenger RNA or mRNA to work inside the body. . . . → Read More: Cell, mRNA Therapy Biotech Raises $165M in Early Funds

Synthetic Bio Chemicals Start-Up Gains $5M in Early Funds

Brewer's yeast

A new enterprise using digital and synthetic biology to create sustainable chemicals at industrial scale is raising $5 million in pre-seed round funds. . . . → Read More: Synthetic Bio Chemicals Start-Up Gains $5M in Early Funds

Immune Disease Biotech Acquired in $405M Deal

Human T-cell

A biotechnology developer of treatments for autoimmune disorders with checkpoint receptor proteins is acquired by drug maker Gilead Sciences. . . . → Read More: Immune Disease Biotech Acquired in $405M Deal

Biotech Start-Up Demonstrates Cancer Therapy, Raises $6.4M

DNA puzzle

A new biotechnology company demonstrated in lab mice its therapy for glioblastoma, an aggressive brain cancer, that overcomes limitations of current treatments. . . . → Read More: Biotech Start-Up Demonstrates Cancer Therapy, Raises $6.4M

Biotechs Discover Antimicrobial Peptide for Food Safety

Harvesting apples

Two biotechnology companies say they discovered a peptide molecule with antimicrobial properties for faster identification and containment of food contamination outbreaks. . . . → Read More: Biotechs Discover Antimicrobial Peptide for Food Safety

Ginkgo Acquires Biomaterials Maker as Industry Consolidates

Digital DNA

A developer of synthetic biology tools and components is acquiring a biological materials developer for its automation assets as the biotechnology industry consolidates. . . . → Read More: Ginkgo Acquires Biomaterials Maker as Industry Consolidates

Infographic – Digital Health Keeps Clicking in 2022

Digital health venture funding

While venture capital funding for digital health start-ups worldwide is down compared to last year, the pace so far in 2022 remains on an historically strong track. . . . → Read More: Infographic – Digital Health Keeps Clicking in 2022

Synthetic Bio Microbiome Biotech Gains $15M in Seed Funds

Stephanie Culler

A developer of therapies produced with synthetic biology for diseases linked to microbes in the gut is raising $15 million in seed financing. . . . → Read More: Synthetic Bio Microbiome Biotech Gains $15M in Seed Funds